Citation: | Ye Xuejun, Lu Xibin, Pan Dengke, et al. Detection methods of non-Gal xenoantibody in human serum[J]. ORGAN TRANSPLANTATION, 2017, 8(2): 132-137. doi: 10.3969/j.issn.1674-7445.2017.02.008 |
[1] |
Ekser B, Ezzelarab M, Hara H, et al. Clinical xenotransplantation: the next medical revolution?[J]. Lancet, 2012, 379(9816):672-683. DOI: 10.1016/S0140-6736(11)61091-X.
|
[2] |
Harnden I, Kiernan K, Kearns-Jonker M. The anti-nonGal xenoantibody response to alpha1, 3-galactosyltransferase gene knockout pig xenografts[J]. Curr Opin Organ Transplant, 2010, 15(2):207-211. DOI: 10.1097/MOT.0b013e328336b854.
|
[3] |
Cooper DK, Ezzelarab MB, Hara H, et al. The pathobiology of pig-to-primate xenotransplantation: a historical review[J]. Xenotransplantation, 2016, 23(2):83-105. DOI: 10.1111/xen.12219.
|
[4] |
Azimzadeh AM, Byrne GW, Ezzelarab M, et al. Development of a consensus protocol to quantify primate anti-non-Gal xenoreactive antibodies using pig aortic endothelial cells[J]. Xenotransplantation, 2014, 21(6):555-566. DOI: 10.1111/xen.12125.
|
[5] |
Butler JR, Skill NJ, Priestman DL, et al. Silencing the porcine iGb3s gene does not affect Galα3Gal levels or measures of anticipated pig-to-human and pig-to-primate acute rejection[J]. Xenotransplantation, 2016, 23(2):106-116. DOI: 10.1111/xen.12217.
|
[6] |
Butler JR, Martens GR, Estrada JL, et al. Silencing porcine genes significantly reduces human-anti-pig cytotoxicity profiles: an alternative to direct complement regulation[J]. Transgenic Res, 2016, 25(5):751-759. DOI: 10.1007/s11248-016-9958-0.
|
[7] |
Estrada JL, Martens G, Li P, et al. Evaluation of human and non-human primate antibody binding to pig cells lacking GGTA1/CMAH/β4GalNT2 genes[J]. Xenotransplantation, 2015, 22(3):194-202. DOI: 10.1111/xen.12161.
|
[8] |
Burlak C, Paris LL, Lutz AJ, et al. Reduced binding of human antibodies to cells from GGTA1/CMAH KO pigs[J]. Am J Transplant, 2014, 14(8):1895-1900. DOI: 10.1111/ajt.12744.
|
[9] |
Lutz AJ, Li P, Estrada JL, et al. Double knockout pigs deficient in N-glycolylneuraminic acid and galactose α-1, 3-galactose reduce the humoral barrier to xenotransplantation[J]. Xenotransplantation, 2013, 20(1):27-35. DOI: 10.1111/xen.12019.
|
[10] |
Lee W, Hara H, Ezzelarab MB, et al. Initial in vitro studies on tissues and cells from GTKO/CD46/NeuGcKO pigs[J]. Xenotransplantation, 2016, 23(2):137-150. DOI: 10.1111/xen.12229.
|
[11] |
Hara H, Long C, Lin YJ, et al. In vitro investigation of pig cells for resistance to human antibody-mediated rejection[J]. Transpl Int, 2008, 21(12):1163-1174. DOI: 10.1111/j.1432-2277.2008.00736.x.
|
[12] |
Rood PP, Tai HC, Hara H, et al. Late onset of development of natural anti-nonGal antibodies in infant humans and baboons: implications for xenotransplantation in infants[J]. Transpl Int, 2007, 20(12):1050-1058. doi: 10.1111/tri.2007.20.issue-12
|
[13] |
Hara H, Ezzelarab M, Rood PP, et al. Allosensitized humans are at no greater risk of humoral rejection of GT-KO pig organs than other humans[J]. Xenotransplantation, 2006, 13(4):357-365. doi: 10.1111/xen.2006.13.issue-4
|
[14] |
Rood PP, Hara H, Busch JL, et al. Incidence and cytotoxicity of antibodies in cynomolgus monkeys directed to nonGal antigens, and their relevance for experimental models[J]. Transpl Int, 2006, 19(2):158-165. doi: 10.1111/tri.2006.19.issue-2
|
[15] |
Ezzelarab M, Hara H, Busch J, et al. Antibodies directed to pig non-Gal antigens in naïve and sensitized baboons[J]. Xenotransplantation, 2006, 13(5):400-407. doi: 10.1111/xen.2006.13.issue-5
|
[16] |
Liang F, Wamala I, Scalea J, et al. Increased levels of anti-non-Gal IgG following pig-to-baboon bone marrow transplantation correlate with failure of engraftment[J]. Xenotransplantation, 2013, 20(6):458-468. DOI: 10.1111/xen.12065.
|
[17] |
Wong BS, Yamada K, Okumi M, et al. Allosensitization does not increase the risk of xenoreactivity to alpha1, 3-galactosyltransferase gene-knockout miniature swine in patients on transplantation waiting lists[J]. Transplantation, 2006, 82(3):314-319. doi: 10.1097/01.tp.0000228907.12073.0b
|